Amyloid β protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity

Journal of Neurochemistry

Volumn 66, Issue 6, 1996, Pages 2468-2476

  Van Muiswinkel, F L ^a,b   Veerhuis, R ^a   Eikelenboom, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Alzheimer's disease; Inflammation; Nitric oxide; Reactive oxygen species; Superoxide anion

Indexed keywords

AMYLOID BETA PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; MICROGLIA; NERVE CELL CULTURE; NEURITE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY BURST; SENILE PLAQUE;

ANIMALIA;

EID: 0029971210     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66062468.x     Document Type: Article

References (58)

1. Aisen P. S. and Davis K. L. (1994) Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiatry 151, 1105-1113.
2. Alley M. C., Scudiero D. A., Monks A., Hursey M. L., Czerwinski M. J., Fine D. L., Abbott B. J., Mayo J. G., Shoemaker R. H., and Boyd M. R. (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601.
3. Balazs L. and Leon M. (1994) Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 9, 1131-1137.
4. Banati R. B., Gehrmann J., Schubert P., and Kreutzberg G. W. (1993) Cytotoxicity of microglia. Glia 7, 111-118.
5. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
6. Ben Yoseph O., Boxer P. A., and Ross B. D. (1994) Oxidative stress in the central nervous system: monitoring the metabolic response using the pentose phosphate pathway. Dev. Neurosci. 16, 328-336.
7. Burger D. and Dayer J.-M. (1995) Inhibitory cytokines and cytokine inhibitors. Neurology 45 (Suppl.), S39-S43.
8. Colton C. A. and Gilbert D. L. (1993) Microglia, an in vivo source of reactive oxygen species in the brain, in Advances in Neurology, Vol. 59: Neural Injury and Regeneration (Seil F. J., ed), pp. 321-326. Raven Press, New York.
9. Colton C. A., Abel C., Patchett J., Keri J. E., and Yao J. (1992) Lectin staining of cultured CNS microglia. J. Histochem. Cytochem. 40, 505-512.
10. Davis J. B., McMurray H. F., and Schubert D. (1992) The amyloid beta-protein of AD is chemotactic for mononuclear phagocytes. Biochem. Biophys. Res. Commun. 189, 1096-1100.
11. Dickson D. W., Lee S. C., Mattiace L. A., Yen S. C., and Brosnan C. (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7, 75-83.
12. Ding A. H., Nathan C. F., and Stuehr D. J. (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141, 2407-2412.
13. Eikelenboom P., Hack C. E., Rozemuller J. M., and Stam F. C. (1989) Complement activation in amyloid plaques in Alzheimer's disease. Virchows Arch. [B] 56, 259-262.
14. Eikelenboom P., Zhan S. S., van Gool W. A., and Allsop D. (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15, 447-450.
15. Friedlich A. L. and Butcher L. L. (1994) Involvement of free oxygen radicals in β-amyloidosis: an hypothesis. Neurobiol. Aging 15, 443-455.
16. Furuta A., Price D. L., Pardo C. A., Troncoso J. C., Xu Z.-S., Taniguchi N., and Martin L. J. (1995) Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am. J. Pathol. 146, 357-367.
17. Giulian D. and Baker T. J. (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6, 2163-2178.
18. Giulian D., Haverkamp L. J., Li J., Karshin W. L., Yu J., Tom D., Li X., and Kirkpatrick J. B. (1995) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27, 119-137.
19. Goodman E. B. and Tenner J. (1992) Signal transduction mechanisms of C1q-mediated superoxide production: evidence for the involvement of temporally distinct staurosporine-insensitive and -sensitive pathways. J. Immunol. 148, 3920-3928.
20. Goodwin J. L., Uemura E., and Cunnick J. E. (1995) Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ. Brain Res. 692, 207-214.
21. Griffin W. S. T., Sheng J. G., Roberts G. W., and Mrak R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276-281.
22. Hamilton T. A. and Adams D. O. (1987) Molecular mechanisms of signal transduction in macrophages. Immunol. Today 8, 151-158.
23. Hamos J., Oblas B., Pulaski-Salo D., Welch W. J., Bole D. G., and Drachman D. A. (1991) Expression of heat shock proteins in Alzheimer's disease. Neurology 41, 345-350.
24. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
25. Howlett D. R., Jennings K. H., Lee D. C., Clark M. S. G., Brown F., Wetzel R., Wood S. J., Camilleri P., and Roberts G. W. (1995) Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4, 23-32.
26. Hu S., Sheng W. S., Peterson P. K., and Chao C. C. (1995) Cytokine modulation of murine microglial cell superoxide production. Glia 13, 45-50.
27. Huell M., Strauss S., Volk B., Berger M., and Bauer J. (1995) Interleukin-6 is present in early stages of plaque formations and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol. (Berl.) 89, 544-551.
28. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and Ihara Y. (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 45-53.
29. Jiang H., Burdick D., Glabe C. G., Cotman C. W., and Tenner A. J. (1994) β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152, 5050-5059.
30. Klegeris A., Walker D. G., and McGeer P. L. (1994) Activation of macrophages by Alzheimer β amyloid peptide. Biochem. Biophys. Res. Commun. 199, 984-991.
31. Korotzer A. R., Pike C. J., and Cotman C. W. (1993) β-Amyloid peptides induce degeneration of cultured rat microglia. Brain Res. 624, 121-125.
32. Korotzer A. R., Watt J., Cribbs D., Tenner A. J., Burdick D., Glabe C., and Cotman C. W. (1995) Cultured rat microglia express C1q and receptor for C1q: implications for amyloid effects on microglia. Exp. Neurol. 134, 214-221.
33. Mackenzie I. R. A., Hao C. H., and Munoz D. G. (1995) Microglia in senile plaque formation. Neurobiol. Aging 16, 797-804.
34. McGeer P. L. and Rogers J. (1992) Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42, 447-449.
35. McGeer P. L., Kawamata T., Walker D. G., Akiyama H., Tooyama I., and McGeer E. G. (1993) Microglia in degenerative neurological disease. Glia 7, 84-92.
36. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., and Rossi F. (1995a) Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374, 647-650.
37. Meda L., Bonaiuto C., Szendrei G. I., Ceska M., Rossi F., and Cassatella M. A. (1995b) β-Amyloid(25-35) induces the production of interleukin-8 from human monocytes. J. Neuroimmunol. 59, 29-33.
38. Morel F., Doussiere J., and Vignais P. V. (1991) The superoxide-generating oxidase of phagocytic cells. Eur. J. Biochem. 201, 523-546.
39. Morrison D. C. and Jacobs D. M. (1976) Binding of polymyxin B to the lipid A protein of bacterial lipopolysaccharide. Immunochemistry 133, 813-820.
40. Phillips W. A. and Hamilton J. A. (1989) Phorbol ester-stimulated superoxide production by murine bone marrow-derived macrophages requires preexposure to cytokines. J. Immunol. 142, 2445-2449.
41. Pick E. and Mizel A. (1981) Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods 46, 211-226.
42. Pike C. J., Walencewicz-Wasserman A. J., Kosmoski J., Cribbs D. H., Glabe C. G., and Cotman C. W. (1995) Structure-activity analysis of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
43. Ponsoda X., Jover R., Castell J. V., and Gómez-Lechón M. J. (1991) Measurement of intracellular LDH activity in 96-well cultures: a rapid and automated assay for cytotoxicity studies. J. Tissue Cult. Methods 13, 21-24.
44. Rogers J., Cooper N. R., Webster S., Schultz J., McGeer P. L., Styren S. D., Civin W. H., Brachova L., Bradt B., Ward P., and Lieberburg I. (1992) Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89, 10016-10020.
45. Rozemuller J. M., Eikelenboom P., Stam F. C., Beyreuther K., and Masters C. L. (1989a) A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J. Neuropathol. Exp. Neurol. 48, 647-663.
46. Rozemuller J. M., Eikelenboom P., Pals S. T., and Stam F. C. (1989b) Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci. Lett. 101, 288-292.
47. Sawada M., Suzumura A., Yamamoto H., and Marunouchi T. (1990) Activation and proliferation of the isolated microglia by colony stimulating factor-1 and possible involvement of protein kinase C. Brain Res. 509, 119-124.
48. Schreck R., Rieber P., and Baeuerle P. A. (1991) Reactive oxygen intermediates are apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
49. Selkoe D. J. (1994) Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease. Curr. Opin. Neurobiol. 4, 708-716.
50. Shaffer L. M., Dority M. D., Gupta-Bansal R., Frederickson R. C. A., Younkin S. G., and Brunden K. R. (1995) Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745.
51. Shigenaga M. K., Hagen T. M., and Ames B. N. (1994) Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA 91, 10771-10778.
52. Smith M. A., Sayre L. M., Monnier V. M., and Perry G. (1995) Radical ageing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
53. Strittmatter W. J. and Roses A. D. (1995) Apolipoprotein E and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 92, 4725-4727.
54. Terry R. D., Masliah E., and Hansen L. A. (1994) Structural basis of the cognitive alterations in Alzheimer's disease, in Alzheimer's Disease (Terry R. D., Katzman R., and Bick K. L., eds), pp. 179-196. Raven Press, New York.
55. Thomas W. E. (1992) Brain macrophages: evaluation of microglia and their functions. Brain Res. Rev. 17, 61-74.
56. Turner N. C., Wood L. J., Burns F. M., Gueremy T., and Souness J. E. (1993) The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Br. J. Pharmacol. 108, 876-883.
57. Walker D. G., Kim S. U., and McGeer P. L. (1995) Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40, 478-493.
58. Zhan S.-S., Veerhuis R., Kamphorst W., and Eikelenboom P. (1995) Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration 4, 291-297.